March 25 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS ANNOUNCES FOURTH QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.32
* Q4 EARNINGS PER SHARE ESTIMATE $-0.22 -- REFINITIV IBES DATA
* FUSION PHARMACEUTICALS - EXPECTS CASH, CASH EQUIVALENTS & INVESTMENTS AS OF DEC. 31, 2020 WILL ENABLE CO TO FUND ITS OPERATIONS THROUGH END OF 2023